In support of this hypothesis, Michaloglou et al. have shown that the combined inhibition of mTORC1/2 and CDK4/6 is necessary to achieve an optimal blockade of the RB-E2F axis and induce long-term inhibition of BC cell growth [25]. Here, RB1 is linked to breast cancer.